| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 70,448 | 78,093 | 77,604 | 88,668 | | Cost of Revenue | 49,705 | 53,774 | 53,570 | 63,404 | | | Gross Profit | 20,743 | 24,319 | 24,034 | 25,264 | | | Operating Expenses | | Research Development | 10,031 | 10,450 | 11,197 | 11,732 | | Selling General and Administrative | 10,960 | 11,362 | 11,812 | 12,122 | | Non Recurring | 183 | 2,957 | 1,478 | 67,256 | | Others | 647 | 647 | 647 | 647 | | | | Total Operating Expenses | 21,821 | 25,416 | 25,134 | 91,757 | | | | Operating Income or Loss | (1,078) | (1,097) | (1,100) | (66,493) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 198 | 344 | 519 | 1,097 | | Earnings Before Interest And Taxes | (880) | (753) | (581) | (65,396) | | Interest Expense | 598 | 596 | 590 | 768 | | Income Before Tax | (1,478) | (1,349) | (1,171) | (66,164) | | Income Tax Expense | (646) | 770 | 38,926 | (9,572) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (832) | (2,119) | (40,097) | (56,592) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (832) | (2,119) | (40,097) | (56,592) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($832) | ($2,119) | ($40,097) | ($56,592) |
|
0.11% Nasdaq 
0.10%
Income Statement
